When conventional IVF cycles have stopped producing a viable pregnancy, or when a uterine factor rules them out entirely, gestational surrogacy abroad often becomes the remaining clinical route to a biological child. The four jurisdictions reviewed here — Kazakhstan, the Kyrgyz Republic, Georgia, and the United Arab Emirates — are the destinations international patients most commonly weigh against one another in 2026. Each operates under a distinct statute, screens patients against different criteria, and produces a different exit-document timeline. What follows compares them across the parameters that actually shift a coordination decision: who qualifies, what genetic material is allowed, whether the program can start before the parents arrive, and what the birth certificate looks like at the end.
What Makes a Jurisdiction Viable for International Patients
Before comparing individual countries, it is worth establishing the criteria that reproductive medicine specialists and legal coordinators apply when evaluating a destination:
●Legal clarity — whether the intended parents are recognized on the birth certificate from the outset, and whether the surrogate retains any residual parental rights after delivery.
●Medical indications — whether the program requires documented medical necessity or is available on broader grounds.
●Eligibility scope — which family types (married couples, unmarried couples, single individuals) are eligible.
●Donor material — whether egg donation, sperm donation, or full embryo donation is permitted alongside surrogacy.
●Embryo import — whether cryopreserved embryos created abroad can be transported and used legally in the program country.
●On-site requirements — how many visits are required, and whether initial stages can be managed remotely.
●Registration outcome — how the birth certificate is issued and what exit documentation process follows.
Each of these factors affects not only legal security but also cost, timeline, and the overall patient experience.
Kazakhstan
Legal Framework
Kazakhstani law confines surrogacy to married couples, and Almaty clinics typically add a one-year marriage threshold as an internal screening requirement rather than a legal one. The statute also requires that at least one intended parent contribute their own gametes — full embryo donation is closed off here, although the use of donor eggs or donor sperm individually remains available where clinically indicated.
Surrogacy contracts must be notarized, and at least one spouse has to attend the notarial appointment in person. Once the child is born, the intended parents go straight onto the medical birth certificate without requiring the surrogate's consent at that stage, though clinics still recommend obtaining her notarized confirmation as a procedural safeguard.
Medical Requirements and Indications
Kazakhstan operates on the medically indicated model. Accepted grounds include congenital or surgical absence of the uterus, severe uterine malformation, endometrial pathology, systemic disease that contraindicates pregnancy, and repeated IVF failure with good-quality embryos. All supporting medical documentation has to be translated into Russian before the receiving clinic will review it.
Donor age eligibility is 18 to 35 years, with comprehensive screening required. Any single donor's gametes are taken out of the available pool once ten children have been born from that source.
Embryo Transport
Cryopreserved embryos from foreign clinics can be imported into Kazakhstan, but the documentation package needs to be assembled before they leave the originating lab. The receiving clinic will request: a certificate listing embryo quantity, cryopreservation date and methodology; a power of attorney covering the courier; current infectious disease test results for both intended parents; and, where applicable, donor identifying information. Both the receiving clinic and the cryo-logistics provider should sign off on the exact document set before shipment.
Patient Pathway Overview
International patients usually make two trips. The first is a three to five day stay covering consultations, notarization, and baseline testing. The second is a five to ten day stay for the birth itself, DNA testing where required, and registration of the birth certificate alongside the child's exit documents. The intervening nine months are managed remotely by the coordination team, with regular medical reporting from the surrogate's attending physicians.
Strengths and Considerations
What recommends Kazakhstan is procedural maturity: the civil registry handles surrogacy births routinely, the clinical sector in Almaty is competent at international ART standards, and the path from notarized contract to birth certificate is short. What rules it out for a sizable share of inquiries is the eligibility filter — unmarried couples, single parents, and any case requiring full embryo donation cannot proceed.
Kyrgyz Republic (Bishkek)
Legal Framework
Of the four jurisdictions in this review, Kyrgyzstan applies the narrowest set of eligibility filters. Foreign nationals — including married couples, unmarried couples living together, single women, and single men — are eligible to participate, and the statute does not require a documented medical indication. The program runs for both medical and personal reasons, which distinguishes it from every other destination compared here.
The framework rests on a single foundational document: a notarized surrogacy agreement between the intended parents and the surrogate. With that agreement properly executed, the surrogate acquires no parental rights and is never entered on the civil registry.
Donor Material and Embryo Use
Both partial and full donor material use is permitted. Cryopreserved embryos created in foreign clinics can be transported to Kyrgyzstan for use in the program. The documentation requirements for embryo import are coordinated between the sending clinic, the receiving clinic in Bishkek, and the cryo-logistics partner.
Patient Pathway and Remote Options
A practical consequence of the Kyrgyz framework is that the early stages can be opened remotely. Powers of attorney and the initial program application can be processed without the parents being physically present at the outset. Travel becomes mandatory only at the delivery stage.
For citizens of the CIS — Russia, Belarus, Kazakhstan, Armenia, Azerbaijan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, and Ukraine — documents require notarization and certified translation into Russian or Kyrgyz under the Minsk Convention. Citizens of every other country need apostille or full diplomatic legalization on top of certified translation.
Birth Registration and Exit Documents
The intended parents appear on the birth certificate once the notarized agreement is on file and the surrogate has signed her written waiver of parental rights. Exit documentation is then assembled at the parents' consulate in Bishkek, with average processing time of two to four weeks depending on the country.
Strengths and Considerations
The Bishkek program is the most flexible of the four on every eligibility axis: family structure, gamete source, and the question of whether IVF has already failed. The absence of a medical indication requirement makes it one of the few jurisdictions globally where a surrogacy program does not depend on a specific diagnosis. Clinically, programs are centered in Bishkek, where IVF and ART capacity has expanded significantly over recent years. The coordination framework benefits from experienced international agency involvement to manage document logistics, particularly for non-CIS nationals.
Georgia (Tbilisi)
Legal Framework
Georgia sits between Kazakhstan and Kyrgyzstan on eligibility: married couples qualify after one year of registered marriage, and unmarried heterosexual couples qualify after one year of documented cohabitation. Single women, single men, and same-sex couples are not eligible under Order No. 18 of the Ministry of Justice of Georgia.
Unmarried couples must provide notarized evidence of cohabitation, which may include address registration documentation, property or tenancy records, a religious marriage certificate, or a clinic-issued certificate confirming at least one year of joint fertility treatment.
The intended parents are recognized as legal parents from the outset. The surrogate retains no parental rights where a properly executed notarized surrogacy agreement is in place.
Donor Programs
Both partial and full donation operate alongside surrogacy in Georgia, but with one defining characteristic: donation in a Georgian surrogacy program is non-anonymous. Where donor gametes were used and IVF took place outside Georgia, the documentation requirement includes a power of attorney from the donor to a representative in Georgia, plus a certified clinic statement identifying the donor by name, signed by the clinic director with notarized signature and a separate authority confirmation. Satisfying that package retrospectively — particularly when anonymous donation was used in the originating country — can be complex. For this reason, clinicians and coordinators often recommend completing IVF within Georgia where donation is involved, since Georgia permits donors of any phenotype.
Embryo Import
Cryopreserved embryos can be imported into Georgia with a specific documentation package: a "before freezing" letter from the originating clinic, a certificate of genetic affinity dated at the time of cryopreservation, a copy of the originating clinic's ART license, and current infectious disease screening results for both partners. For cases originating in the Russian Federation, notarization requirements on certain documents can be difficult to satisfy in full; this carries procedural risk that should be discussed with the legal team before embryos leave the originating lab.
Birth Certificate and Exit Documents
The birth certificate is issued by the Agency under the Ministry of Justice, with a representative able to submit the application on behalf of the intended parents. Processing time runs from five days to one month. Parents need to be in country by the time of birth. Exit documentation depends on the home country's consular schedule and typically takes between two weeks and two months.
Strengths and Considerations
Tbilisi's ART sector is mature, the legal pathway is well-trodden, and documentation procedures are relatively accessible for many European and CIS nationals. The point where Georgia programs most commonly stall is donor documentation — particularly for cases where the embryo was created abroad using anonymous donor gametes, since Georgia requires non-anonymous donor identification at the documentation level. The requirement for a genetic link to at least one parent and the restrictions on eligible family types are the primary legal parameters to weigh before selecting this jurisdiction.
United Arab Emirates (Abu Dhabi)
Legal Framework
Abu Dhabi's surrogacy regime sits at the opposite end of the regulatory spectrum from Kyrgyzstan's. Law established a fully committee-supervised pathway under the Department of Health (DoH), with each case approved individually by the DoH Medical Committee for Gestational Surrogacy before any clinical work begins. The framework is recent, but its procedural density and clinical safety standards exceed anything else in the region.
The program is available exclusively to legally married heterosexual couples — both UAE residents and foreign nationals — provided every medical and procedural criterion is satisfied. A defining regulatory feature is that the embryo must derive exclusively from the intended parents' own genetic material. Donor egg, donor sperm, and full embryo donation are all closed off inside the UAE program. This single restriction is the most consequential difference between Abu Dhabi and the other three destinations in this review.
Both intended parents must be at least 21 years of age. The DoH Medical Committee, composed of academic clinicians and healthcare regulatory representatives, reviews and signs off each case before treatment proceeds.
Medical Indications
Eligibility requires documented medical necessity: congenital or surgical absence of the uterus, severe uterine or endometrial abnormalities, life-threatening contraindications to pregnancy, or a history of repeated IVF failure or recurrent pregnancy loss. Each indication has to be confirmed by a treating physician and ratified by the DoH committee.
Clinical Process and Pre-implantation Requirements
The UAE framework permits only IVF as the ART method underpinning the surrogacy arrangement. Pre-implantation Genetic Testing for Aneuploidy (PGT-A) is mandatory for every embryo. PGT-M and PGT-SR are added based on whole exome sequencing or karyotyping results. Only single embryo transfers are permitted, with no clinical discretion to deviate.
Clinical work is conducted at DoH-designated licensed facilities. The most intensive phase — ovarian stimulation, retrieval, fertilization, and embryo development — can be completed at Samaa Clinic in Dubai. Embryos are then transported to Abu Dhabi for transfer to the surrogate under DoH-regulated chain of custody. The program can only be coordinated through an accredited agency; international groups such as Embrymama operate inside that accredited framework.
Surrogate Eligibility
Surrogate candidates must be aged 21 to 45, with a BMI between 19 and 30. The obstetric history requirement specifies at least one but no more than five prior full-term deliveries, and no more than two prior cesarean sections. Full medical and psychological evaluation is mandatory, and where the surrogate is married her husband must provide written consent.
Screening Requirements
Both intended parents and the surrogate complete the full infectious disease panel: HIV I and II, HBsAg, HBsAb, anti-HCV, syphilis (RPR/VDRL), gonorrhea, chlamydia, and rubella IgG. The intended mother additionally completes hormonal evaluation, AMH, CBC, TSH, prolactin, estradiol, vitamin D, Pap smear, high vaginal swab, uterine ultrasound with hysteroscopy where indicated, and hemoglobin electrophoresis. Karyotyping of both parents is required. Genetic carrier screening is mandatory to identify heritable conditions.
Embryo Import
Embryos created outside the UAE can be used in an Abu Dhabi program, but only where the pre-conception testing performed on the parents matches the DoH's specified infectious disease panel in full, and only where the embryo derives entirely from the parents' own gametes.
Program Initiation and Presence Requirements
Unlike Kyrgyzstan, Abu Dhabi cannot be initiated by power of attorney. The intended parents must attend the initial medical consultation in person. Mandatory insurance covering the surrogate's transfer, pregnancy, and delivery costs has to be arranged and funded by the intended parents before treatment begins.
Birth Registration and Legal Outcome
At birth, the intended parents are recognized as legal parents. The surrogate relinquishes all parental rights and responsibilities by operation of the notarized tripartite agreement. The birth certificate is issued in accordance with the agreement's terms. Exit documentation is then obtained through the parents' home country consulate in the UAE, typically clearing in two to four weeks.
Strengths and Considerations
For patients who satisfy the eligibility criteria — a legally married heterosexual couple, both willing and able to contribute their own gametes — Abu Dhabi delivers the most clinically conservative program available in the region: mandatory PGT-A on every embryo, single embryo transfer only, hospital-only delivery at DoH-designated facilities, and a documented committee approval trail behind every case. The same features that produce that safety profile also produce its eligibility ceiling. Donor gametes are not permitted under any circumstance, the program cannot begin before the parents are physically present, and the surrogate-side screening (BMI 19 to 30, between one and five prior full-term deliveries, no more than two prior cesareans) is among the strictest in published ART regulation worldwide.
Comparative Summary
Clinical Perspective
Read in clinical rather than legal terms, the four jurisdictions cluster into two patterns. Abu Dhabi enforces a single, evidence-aligned protocol on every case: aneuploidy screening before transfer, one embryo at a time, delivery in a designated hospital. The other three jurisdictions retain clinical flexibility — donor gametes where indicated, double embryo transfer where clinically defended, broader use of imported embryos — at the cost of less standardized oversight from case to case.
Neither pattern is medically superior in the abstract. A 32-year-old patient with a single high-quality euploid embryo and a uterine factor will see almost no clinical difference between the four. A 41-year-old patient with diminished ovarian reserve, two prior failed transfers, and a need for donor eggs will see the difference as decisive: three of the four jurisdictions remain open to her, the UAE does not.
The decision belongs at the intersection of the patient's medical profile, family structure, embryo status, and acceptable timeline. An integrated consultation across the fertility specialist, the legal coordinator, and an experienced international agency is the only reliable way to keep that intersection in view.
Coordination Considerations
International surrogacy runs on three parallel timelines: clinical, legal, and logistical. The quality of coordination — document management, embryo chain of custody, surrogate monitoring protocols, and liaison with the registering authority — has more impact on both clinical outcomes and final legal security than most patients anticipate at the inquiry stage. Agencies operating across multiple legal jurisdictions are better placed to match a patient to the right destination than agencies tied to a single program model, simply because they are not arguing against their own placement incentives.
Disclaimer: This article is provided for informational purposes only and does not constitute legal or medical advice. Regulatory frameworks change, and clinic-level requirements can shift between publication and the date of any specific inquiry. Intended parents should obtain current legal and clinical consultation before initiating any program.
For information on gestational surrogacy coordination across these jurisdictions, see website of embrymama.